Literature DB >> 26721543

Disease stage, but not sex, predicts depression and psychological distress in Huntington's disease: A European population study.

Maria Dale1, John Maltby2, Steve Shimozaki1, Rebecca Cramp1, Hugh Rickards1.   

Abstract

OBJECTIVE: Depression and anxiety significantly affect morbidity in Huntington's disease. Mice. models of Huntington's disease have identified sex differences in mood-like behaviours that vary across disease lifespan, but this interaction has not previously been explored in humans with Huntington's disease. However, among certain medical populations, evidence of sex differences in mood across various disease stages has been found, reflecting trends among the general population that women tend to experience anxiety and depression 1.5 to 2 times more than men. The current study examined whether disease stage and sex, either separately or as an interaction term, predicted anxiety and depression in Huntington's disease.
METHODS: A cross-sectional study of REGISTRY data involving 453 Huntington's disease participants from 12 European countries was undertaken using the Hospital Anxiety and Depression Scale. A series of multiple regression analyses were undertaken to discover to what extent disease stage and sex predicted anxiety, depression, and general distress after controlling for a number of known predictors of mood difficulties.
RESULTS: Disease stage, but not sex, was found to predict depressive symptoms and general distress. Neither disease stage nor sex predicted anxiety. Furthermore, an interaction term computed for disease stage and sex did not contribute to the models tested.
CONCLUSION: In terms of considering risks to developing depression and anxiety in the Huntington's disease population, practitioners may need to pay special attention to disease stage progression (but not sex differences) to enable early detection and treatment of depression (but not anxiety).
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Disease stage; HADS; Huntington disease; Sex

Mesh:

Year:  2015        PMID: 26721543     DOI: 10.1016/j.jpsychores.2015.11.003

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  6 in total

1.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

2.  The Confluence of Psychiatric Symptoms and Neurodegenerative Disease: Impact on Genetic Counseling.

Authors:  Jill S Goldman; Edward D Huey; Deborah Z Thorne
Journal:  J Genet Couns       Date:  2016-12-24       Impact factor: 2.537

Review 3.  Association between sex and Huntington's disease: an updated review on symptomatology and prognosis of neurodegenerative disorders.

Authors:  Nimra Hasnain; Taha Bin Arif; Roha Shafaut; Faiza Zakaria; Syeda Zainab Fatima; Ibtehaj Ul Haque
Journal:  Wien Med Wochenschr       Date:  2022-06-20

4.  Sex Differences in Huntington's Disease: Evaluating the Enroll-HD Database.

Authors:  Samantha Hentosh; Liang Zhu; Jorge Patino; J Weldon Furr; Natalia P Rocha; Erin Furr Stimming
Journal:  Mov Disord Clin Pract       Date:  2021-03-08

5.  Age at Death and Causes of Death in Patients with Huntington Disease in Norway in 1986-2015.

Authors:  Olga Karin Solberg; Petra Filkuková; Jan C Frich; Kristin J Billaud Feragen
Journal:  J Huntingtons Dis       Date:  2018

6.  Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy.

Authors:  Alice Lopes; Isabel Fonseca; Alexandra Sousa; Margarida Branco; Carla Rodrigues; Teresa Coelho; Jorge Sequeiros; Paula Freitas
Journal:  Biomed Hub       Date:  2017-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.